Breaking News Bar

Business News and Information

The Daily Herald Market Index
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Local Stocks
NEPTUNE TECH&BIO RG (NQ: NEPT)
2.730 USD  +0.010 (+0.37%)
Official Closing Price  /  Updated: 8:00 PM EDT, Apr 26, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 210,240
Open 2.730
Bid (Size) 2.480 (500)
Ask (Size) 2.780 (1000)
Prev. Close 2.720
Today's Range 2.660 - 2.750
52wk Range 0.7000 - 3.590
Shares Outstanding 78,781,173
Dividend Yield N/A
Performance
YTD
+14.23%
+14.23%
1 Month
-3.87%
-3.87%
3 Month
-17.52%
-17.52%
6 Month
+217.44%
+217.44%
1 Year
+165.05%
+165.05%
Top News
More News
Technical Perspectives on Biotech Stocks -- Neptune Technologies & Bioressources, Neuralstem, NewLink Genetics, and OHR Pharma
WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on NEPT, CUR, NLNK, and OHRP which can be accessed for free by signing up to... Read More
from PR Newswire
Horizons ETFs Completes Rebalance of its Marijuana Life Sciences Index ETF
from PR Newswire
More News
Read More
Free Research Reports on These Biotech Stocks -- Navidea Biopharma, Nektar Therapeutics, Mirati Therapeutics, and Neptune Technologies & Bioressources
from PR Newswire
Neptune annonce ses résultats pour le troisième trimestre
from Marketwired
Neptune Announces Third Quarter Results
from Marketwired News Releases
Neptune et Tetra Bio-Pharma concluent une entente de codéveloppement de produits antidouleurs et anti-inflammatoires à base d'huiles de cannabinoïdes purifiés
from Marketwired
Neptune and Tetra Bio-Pharma Enter Co-Development Agreement for Purified Cannabinoid Oil-Based Products targeting Pain and Inflammation
from Marketwired News Releases
Neptune and Tetra Bio-Pharma Enter Co-Development Agreement for Purified Cannabinoid Oil-Based Products targeting Pain and Inflammation
from Marketwired
Neptune and Tetra Bio-Pharma Enter Co-Development Agreement for Purified Cannabinoid Oil-Based Products targeting Pain and Inflammation
from Marketwired News Releases
Neptune publiera ses résultats du troisième trimestre pour la période intermédiaire terminée le 31 décembre 2017
from Marketwired
Neptune to Hold Conference Call to Discuss Third Quarter Results for the Interim Period Ended December 31, 2017
from Marketwired News Releases
Stock Market JSON API provided by www.cloudquote.net
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
 
bottom clear
Search DailyHerald.com for articles
More ways to search Daily Herald
Obituaries
Search DailyHerald.com obituaries. » Daily Herald newspaper archive
Find archived newspaper articles back to 1901. »
Digital Subscriptions
Activate Subscriber Access Purchase a Digital Subscription
Home Delivery
Start a New Subscription Manage Account